Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2003 Nov 15;376(Pt 1):169–178. doi: 10.1042/BJ20030988

L-alanine-glyoxylate aminotransferase II of rat kidney and liver mitochondria possesses cysteine S-conjugate beta-lyase activity: a contributing factor to the nephrotoxicity/hepatotoxicity of halogenated alkenes?

Arthur J L Cooper 1, Boris F Krasnikov 1, Etsuo Okuno 1, Thomas M Jeitner 1
PMCID: PMC1223738  PMID: 12859250

Abstract

Several halogenated alkenes are metabolized in part to cysteine S-conjugates, which are mitochondrial toxicants of kidney and, to a lesser extent, other organs. Toxicity is due to cysteine S-conjugate beta-lyases, which convert the cysteine S-conjugate into pyruvate, ammonia and a reactive sulphur-containing fragment. A section of the human population is exposed to halogenated alkenes. To understand the health effects of such exposure, it is important to identify cysteine S-conjugate beta-lyases that contribute to mitochondrial damage. Mitochondrial aspartate aminotransferase [Cooper, Bruschi, Iriarte and Martinez-Carrion (2002) Biochem. J. 368, 253-261] and mitochondrial branched-chain aminotransferase [Cooper, Bruschi, Conway and Hutson (2003) Biochem. Pharmacol. 65, 181-192] exhibit beta-lyase activity toward S -(1,2-dichlorovinyl)-L-cysteine (the cysteine S-conjugate of trichloroethylene) and S -(1,1,2,2-tetrafluoroethyl)-L-cysteine (the cysteine S-conjugate of tetrafluoroethylene). Turnover leads to eventual inactivation of these enzymes. Here we report that mitochondrial L-alanine-glyoxylate aminotransferase II, which, in the rat, is most active in kidney, catalyses cysteine S-conjugate beta-lyase reactions with S -(1,1,2,2-tetrafluoroethyl)-L-cysteine, S -(1,2-dichlorovinyl)-L-cysteine and S -(benzothiazolyl-L-cysteine); turnover leads to inactivation. Previous workers showed that the reactive-sulphur-containing fragment released from S -(1,1,2,2-tetrafluoroethyl)-L-cysteine and S -(1,2-dichlorovinyl)-L-cysteine is toxic by acting as a thioacylating agent - particularly of lysine residues in nearby proteins. Toxicity, however, may also involve 'self-inactivation' of key enzymes. The present findings suggest that alanine-glyoxylate aminotransferase II may be an important factor in the well-established targeting of rat kidney mitochondria by toxic halogenated cysteine S-conjugates. Previous reports suggest that alanine-glyoxylate aminotransferase II is absent in some humans, but present in others. Alanine-glyoxylate aminotransferase II may contribute to the bioactivation (toxification) of halogenated cysteine S-conjugates in a subset of individuals exposed to halogenated alkenes.

Full Text

The Full Text of this article is available as a PDF (179.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders M. W., Dekant W. Glutathione-dependent bioactivation of haloalkenes. Annu Rev Pharmacol Toxicol. 1998;38:501–537. doi: 10.1146/annurev.pharmtox.38.1.501. [DOI] [PubMed] [Google Scholar]
  2. Bruschi S. A., Lindsay J. G., Crabb J. W. Mitochondrial stress protein recognition of inactivated dehydrogenases during mammalian cell death. Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13413–13418. doi: 10.1073/pnas.95.23.13413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bruschi S. A., West K. A., Crabb J. W., Gupta R. S., Stevens J. L. Mitochondrial HSP60 (P1 protein) and a HSP70-like protein (mortalin) are major targets for modification during S-(1,1,2,2-tetrafluoroethyl)-L-cysteine-induced nephrotoxicity. J Biol Chem. 1993 Nov 5;268(31):23157–23161. [PubMed] [Google Scholar]
  4. Brüning T., Weirich G., Hornauer M. A., Höfler H., Brauch H. Renal cell carcinomas in trichloroethene (TRI) exposed persons are associated with somatic mutations in the von Hippel-Lindau (VHL) tumour suppressor gene. Arch Toxicol. 1997;71(5):332–335. doi: 10.1007/s002040050394. [DOI] [PubMed] [Google Scholar]
  5. Bull R. J. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ Health Perspect. 2000 May;108 (Suppl 2):241–259. doi: 10.1289/ehp.00108s2241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooper A. J. Mechanisms of cysteine S-conjugate beta-lyases. Adv Enzymol Relat Areas Mol Biol. 1998;72:199–238. doi: 10.1002/9780470123188.ch6. [DOI] [PubMed] [Google Scholar]
  7. Cooper A. J., Wang J., Gartner C. A., Bruschi S. A. Co-purification of mitochondrial HSP70 and mature protein disulfide isomerase with a functional rat kidney high-M(r) cysteine S-conjugate beta-lyase. Biochem Pharmacol. 2001 Nov 15;62(10):1345–1353. doi: 10.1016/s0006-2952(01)00802-4. [DOI] [PubMed] [Google Scholar]
  8. Cooper Arthur J. L., Bruschi Sam A., Anders M. W. Toxic, halogenated cysteine S-conjugates and targeting of mitochondrial enzymes of energy metabolism. Biochem Pharmacol. 2002 Aug 15;64(4):553–564. doi: 10.1016/s0006-2952(02)01076-6. [DOI] [PubMed] [Google Scholar]
  9. Cooper Arthur J. L., Bruschi Sam A., Conway Myra, Hutson Susan M. Human mitochondrial and cytosolic branched-chain aminotransferases are cysteine S-conjugate beta-lyases, but turnover leads to inactivation. Biochem Pharmacol. 2003 Jan 15;65(2):181–192. doi: 10.1016/s0006-2952(02)01513-7. [DOI] [PubMed] [Google Scholar]
  10. Cooper Arthur J. L., Bruschi Sam A., Iriarte Ana, Martinez-Carrion Marino. Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions. Biochem J. 2002 Nov 15;368(Pt 1):253–261. doi: 10.1042/BJ20020531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cummings B. S., Lash L. H. Metabolism and toxicity of trichloroethylene and S-(1,2-dichlorovinyl)-L-cysteine in freshly isolated human proximal tubular cells. Toxicol Sci. 2000 Feb;53(2):458–466. doi: 10.1093/toxsci/53.2.458. [DOI] [PubMed] [Google Scholar]
  12. Danpure C. J. Variable peroxisomal and mitochondrial targeting of alanine: glyoxylate aminotransferase in mammalian evolution and disease. Bioessays. 1997 Apr;19(4):317–326. doi: 10.1002/bies.950190409. [DOI] [PubMed] [Google Scholar]
  13. Dekant W., Lash L. H., Anders M. W. Bioactivation mechanism of the cytotoxic and nephrotoxic S-conjugate S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7443–7447. doi: 10.1073/pnas.84.21.7443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. GREIFF D., MYERS M., PRIVITERA C. A. The effects of glycerol, freezing and storage at low temperatures, and drying by vacuum sublimation on oxidative phosphorvlation by mitochondrial suspensions. Biochim Biophys Acta. 1961 Jun 24;50:233–242. doi: 10.1016/0006-3002(61)90321-3. [DOI] [PubMed] [Google Scholar]
  15. Green T., Odum J., Nash J. A., Foster J. R. Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans. Toxicol Appl Pharmacol. 1990 Mar 15;103(1):77–89. doi: 10.1016/0041-008x(90)90264-u. [DOI] [PubMed] [Google Scholar]
  16. Green T., Odum J. Structure/activity studies of the nephrotoxic and mutagenic action of cysteine conjugates of chloro- and fluoroalkenes. Chem Biol Interact. 1985 Jun;54(1):15–31. doi: 10.1016/s0009-2797(85)80149-6. [DOI] [PubMed] [Google Scholar]
  17. HOPPER S., SEGAL H. L. COMPARATIVE PROPERTIES OF GLUTAMIC-ALANINE TRANSAMINASE FROM SEVERAL SOURCES. Arch Biochem Biophys. 1964 Jun;105:501–505. doi: 10.1016/0003-9861(64)90042-6. [DOI] [PubMed] [Google Scholar]
  18. Hayden P. J., Stevens J. L. Cysteine conjugate toxicity, metabolism, and binding to macromolecules in isolated rat kidney mitochondria. Mol Pharmacol. 1990 Mar;37(3):468–476. [PubMed] [Google Scholar]
  19. James Eric A., Gygi Steven P., Adams Michael L., Pierce Robert H., Fausto Nelson, Aebersold Ruedi H., Nelson Sidney D., Bruschi Sam A. Mitochondrial aconitase modification, functional inhibition, and evidence for a supramolecular complex of the TCA cycle by the renal toxicant S-(1,1,2,2-tetrafluoroethyl)-L-cysteine. Biochemistry. 2002 May 28;41(21):6789–6797. doi: 10.1021/bi020038j. [DOI] [PubMed] [Google Scholar]
  20. Kontani Y., Kaneko M., Kikugawa M., Fujimoto S., Tamaki N. Identity of D-3-aminoisobutyrate-pyruvate aminotransferase with alanine-glyoxylate aminotransferase 2. Biochim Biophys Acta. 1993 Feb 13;1156(2):161–166. doi: 10.1016/0304-4165(93)90131-q. [DOI] [PubMed] [Google Scholar]
  21. Lash L. H., Anders M. W. Cytotoxicity of S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. J Biol Chem. 1986 Oct 5;261(28):13076–13081. [PubMed] [Google Scholar]
  22. Lash L. H., Hueni S. E., Putt D. A. Apoptosis, necrosis, and cell proliferation induced by S-(1,2-dichlorovinyl)-L-cysteine in primary cultures of human proximal tubular cells. Toxicol Appl Pharmacol. 2001 Nov 15;177(1):1–16. doi: 10.1006/taap.2001.9295. [DOI] [PubMed] [Google Scholar]
  23. Lash L. H., Parker J. C., Scott C. S. Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect. 2000 May;108 (Suppl 2):225–240. doi: 10.1289/ehp.00108s2225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lee I. S., Muragaki Y., Ideguchi T., Hase T., Tsuji M., Ooshima A., Okuno E., Kido R. Molecular cloning and sequencing of a cDNA encoding alanine-glyoxylate aminotransferase 2 from rat kidney. J Biochem. 1995 Apr;117(4):856–862. doi: 10.1093/oxfordjournals.jbchem.a124787. [DOI] [PubMed] [Google Scholar]
  25. Lock E. A., Ishmael J. The nephrotoxicity and hepatotoxicity of 1,1,2,2-tetrafluoroethyl-L-cysteine in the rat. Arch Toxicol. 1998 May;72(6):347–354. doi: 10.1007/s002040050513. [DOI] [PubMed] [Google Scholar]
  26. Lumb M. J., Danpure C. J. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem. 2000 Nov 17;275(46):36415–36422. doi: 10.1074/jbc.M006693200. [DOI] [PubMed] [Google Scholar]
  27. Morino Y., Kojima H., Tanase S. Affinity labeling of alanine aminotransferase by 3-chloro-L-alanine. J Biol Chem. 1979 Jan 25;254(2):279–285. [PubMed] [Google Scholar]
  28. Morino Y., Osman A. M., Okamoto M. Formate-induced labeling of the active site of aspartate aminotransferase by beta-chloro-L-alanine. J Biol Chem. 1974 Oct 25;249(20):6684–6692. [PubMed] [Google Scholar]
  29. Odum J., Green T. The metabolism and nephrotoxicity of tetrafluoroethylene in the rat. Toxicol Appl Pharmacol. 1984 Nov;76(2):306–318. doi: 10.1016/0041-008x(84)90012-7. [DOI] [PubMed] [Google Scholar]
  30. Ogawa T., Kimoto M., Sasaoka K. Dimethylarginine:pyruvate aminotransferase in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. J Biol Chem. 1990 Dec 5;265(34):20938–20945. [PubMed] [Google Scholar]
  31. Okuno E., Minatogawa Y., Kido R. Co-purification of alanine-glyoxylate aminotransferase with 2-aminobutyrate aminotransferase in rat kidney. Biochim Biophys Acta. 1982 Mar 15;715(1):97–104. doi: 10.1016/0304-4165(82)90054-x. [DOI] [PubMed] [Google Scholar]
  32. Park L. C., Gibson G. E., Bunik V., Cooper A. J. Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-L-cysteine. Biochem Pharmacol. 1999 Nov 15;58(10):1557–1565. doi: 10.1016/s0006-2952(99)00247-6. [DOI] [PubMed] [Google Scholar]
  33. Pfaller W., Gstraunthaler G. Nephrotoxicity testing in vitro--what we know and what we need to know. Environ Health Perspect. 1998 Apr;106 (Suppl 2):559–569. doi: 10.1289/ehp.98106559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Porter D. J., Harrington J. A., Almond M. R., Chestnut W. G., Tanoury G., Spector T. Enzymatic elimination of fluoride from alpha-fluoro-beta-alanine. Biochem Pharmacol. 1995 Oct 26;50(9):1475–1484. doi: 10.1016/0006-2952(95)02053-5. [DOI] [PubMed] [Google Scholar]
  35. Soper T. S., Manning J. M. beta-elimination of beta-halo substrates by D-amino acid transaminase associated with inactivation of the enzyme. Trapping of a key intermediate in the reaction. Biochemistry. 1978 Aug 8;17(16):3377–3384. doi: 10.1021/bi00609a031. [DOI] [PubMed] [Google Scholar]
  36. Stevens J. L. Isolation and characterization of a rat liver enzyme with both cysteine conjugate beta-lyase and kynureninase activity. J Biol Chem. 1985 Jul 5;260(13):7945–7950. [PubMed] [Google Scholar]
  37. Stevens J. L., Robbins J. D., Byrd R. A. A purified cysteine conjugate beta-lyase from rat kidney cytosol. Requirement for an alpha-keto acid or an amino acid oxidase for activity and identity with soluble glutamine transaminase K. J Biol Chem. 1986 Nov 25;261(33):15529–15537. [PubMed] [Google Scholar]
  38. Takada Y., Noguchi T. Subcellular distribution, and physical and immunological properties of hepatic alanine: glyoxylate aminotransferase isoenzymes in different mammalian species. Comp Biochem Physiol B. 1982;72(4):597–604. doi: 10.1016/0305-0491(82)90512-0. [DOI] [PubMed] [Google Scholar]
  39. Taniguchi K., Tsujio T., Karimoto Y. Deficiency of D-beta-aminoisobutyrate: pyruvate aminotransferase in the liver of genetic high excretors of D-beta-aminoisobutyrate. Biochim Biophys Acta. 1972 Oct 25;279(3):475–480. doi: 10.1016/0304-4165(72)90168-7. [DOI] [PubMed] [Google Scholar]
  40. Ueno H., Likos J. J., Metzler D. E. Chemistry of the inactivation of cytosolic aspartate aminotransferase by serine O-sulfate. Biochemistry. 1982 Aug 31;21(18):4387–4393. doi: 10.1021/bi00261a030. [DOI] [PubMed] [Google Scholar]
  41. Varticovski L., Kushner J. P., Burnham B. F. Biosynthesis of porphyrin precursors. Purification and characterization of mammalian L-alanine:gamma,delta-dioxovaleric acid aminotransferase. J Biol Chem. 1980 Apr 25;255(8):3742–3747. [PubMed] [Google Scholar]
  42. Wartenberg D., Reyner D., Scott C. S. Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect. 2000 May;108 (Suppl 2):161–176. doi: 10.1289/ehp.00108s2161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wu C., Schaum J. Exposure assessment of trichloroethylene. Environ Health Perspect. 2000 May;108 (Suppl 2):359–363. doi: 10.1289/ehp.00108s2359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yamauchi A., Stijntjes G. J., Commandeur J. N., Vermeulen N. P. Purification of glutamine transaminase K/cysteine conjugate beta-lyase from rat renal cytosol based on hydrophobic interaction HPLC and gel permeation FPLC. Protein Expr Purif. 1993 Dec;4(6):552–562. doi: 10.1006/prep.1993.1073. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES